Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.57 |
| ▸ | CDC25A | P30304 | 1/20 | 0.57 |
| ▸ | PTPRC | P08575 | 7/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | S100A4 | P26447 | 3/20 | 0.39 |
| ▸ | APAF1 | O14727 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | GALK1 | P51570 | 3/20 | 0.39 |
| ▸ | BLM | P54132 | 3/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 3/20 | 0.39 |
| ▸ | TDP2 | O95551 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133450 | 0.76 | PTPN1 (0.55) | CDC25BPTPRCMEN1KMT2ALMNA | |
| SCHEMBL24224703 | 0.73 | CDC25B (1.00) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL31619928 | 0.67 | CDC25B (0.89) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL11828689 | 0.67 | CDC25B (0.89) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL6233550 | 0.66 | CDC25B (0.52) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL30003397 | 0.66 | CDC25B (0.52) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL4310782 | 0.66 | CDC25A (0.56) | CDC25BCDC25APTPRCMEN1KMT2A | |
| SCHEMBL8607876 | 0.65 | MAOA (0.56) | CDC25BPTPRCMEN1KMT2ALMNA | |
| SCHEMBL11585770 | 0.64 | ADORA2A (0.50) | CDC25BPTPRCMEN1KMT2ALMNA | |
| SCHEMBL5656918 | 0.64 | MEN1 (0.32) | CDC25BCDC25APTPRCMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215145-A1 | METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE | MD BIOALPHA CO., LTD. (KR) | 2009-08-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215145-A1 | METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE | NQO1, NADK, ME2 | CDC25B 2415/4885CDC25A 1750/4885PTPRC 1755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.